You have 9 free searches left this month | for more free features.

Gastric Inhibitory Polypeptide

Showing 1 - 25 of 5,990

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 Diabetes Trial in Al Ain (GIP/GLP-1a)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +3 more
  • Al Ain, Abu Dhabi, United Arab Emirates
    Internal Medicine, College of Medicine and Health Sciences
Mar 1, 2023

Healthy Trial in Oxford (25 g Nutralys Pea Protein, 50 g Nutralys S85 Plus., 50 g Glucose)

Completed
  • Healthy
  • 25 g Nutralys Pea Protein
  • +2 more
  • Oxford, United Kingdom
    Oxford Brookes Centre for Nutrition and Health
Oct 29, 2020

Type 2 Diabetes, Obesity Trial in Hellerup (Semaglutide 1.34 MG/ML [Ozempic], Glucose-dependent insulinotropic polypeptide

Recruiting
  • Type 2 Diabetes
  • Obesity
  • Semaglutide 1.34 MG/ML [Ozempic]
  • +3 more
  • Hellerup, Capital Region, Denmark
    Center for Clinical Metabolic Research, Gentofte Hospital
May 19, 2022

Childhood Obesity Trial (Meal replacement and lifestyle modification)

Not yet recruiting
  • Childhood Obesity
  • Meal replacement and lifestyle modification
  • (no location specified)
Jan 10, 2023

Type 2 Diabetes Trial in Nottingham (BetaQuik™, WheyBasics, Iso-voluminous water)

Completed
  • Type 2 Diabetes
  • BetaQuik™
  • +2 more
  • Nottingham, United Kingdom
    University of Nottingham
Aug 15, 2022

Hypertriglyceridemia Trial in Hellerup (DHA-NAT, Placebo)

Recruiting
  • Hypertriglyceridemia
  • DHA-NAT
  • Placebo
  • Hellerup, Denmark
    Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
Jul 11, 2023

Obesity Trial (LaKe Ester, Placebo)

Not yet recruiting
  • Obesity
  • LaKe Ester
  • Placebo
  • (no location specified)
Jun 14, 2023

Bariatric Surgery Trial in Hvidovre (Placebo, GLP-1 antagonism, GIP antagonism)

Completed
  • Bariatric Surgery
  • Placebo
  • +3 more
  • Hvidovre, Denmark
  • +1 more
Jan 31, 2022

Blood Glucose Fluctuations, Hunger Trial in Vienna (Sucrose, Hesperetin)

Not yet recruiting
  • Blood Glucose Fluctuations
  • Hunger
  • Vienna, Austria
    Christian Doppler Laboratory for Taste Research
Jan 26, 2023

Type 2 Diabetes, Ketoses, Metabolic Trial in Aarhus (3-hydroxybutyrate)

Recruiting
  • Type 2 Diabetes
  • Ketoses, Metabolic
  • 3-hydroxybutyrate
  • Aarhus, Denmark
    Medical research laboratory, Department of endocrinology, Aarhus
Apr 5, 2022

Type 2 Diabetes (T2DM) Trial (Endovascular Denervation System (Netrod))

Not yet recruiting
  • Type 2 Diabetes Mellitus (T2DM)
  • Endovascular Denervation System (Netrod)
  • (no location specified)
Jan 5, 2023

Obesity Trial (Endobariatric procedure)

Not yet recruiting
  • Obesity
  • Endobariatric procedure
  • (no location specified)
Aug 22, 2022

Overweight and Obesity, Type 2 Diabetes Trial in Chicago (Water, Glucose, Steviol Glycosides)

Enrolling by invitation
  • Overweight and Obesity
  • Type 2 Diabetes Mellitus
  • Water
  • +4 more
  • Naples, Florida
  • +1 more
Dec 9, 2022

Diabetes, Type 1 Trial in Hellerup (glucose-dependent insulinotropic peptide, Glucose-Dependent Insulin-Releasing Hormone[3-30],

Completed
  • Diabetes Mellitus, Type 1
  • glucose-dependent insulinotropic peptide
  • +2 more
  • Hellerup, Denmark
    Steno Diabetes Center Copenhagen, Clinical Metabolic Physiology
May 5, 2021

Obesity, Abdominal Trial in Aarhus (Placebo, Cafestol)

Active, not recruiting
  • Obesity, Abdominal
  • Placebo
  • Cafestol
  • Aarhus, Aarhus N, Denmark
    Steno Diabetes Center Aarhus
Jan 4, 2023

Obesity, Diabetes, Type 2 Trial in Toronto (Dairy and plant-based dairy beverages and solids)

Completed
  • Obesity
  • Diabetes Mellitus, Type 2
  • Dairy and plant-based dairy beverages and solids
  • Toronto, Ontario, Canada
    Department of Nutritional Sciences, C. David Naylor Building
Jun 22, 2023

Acute Ischemic Stroke Trial in Aarhus (Semaglutide, Standard care)

Not yet recruiting
  • Acute Ischemic Stroke
  • Aarhus, Denmark
    Aarhus University Hospital
Dec 9, 2022

Gastric Emptying - Implications for Pathogenesis of Type 2

Recruiting
  • Diabetes Mellitus, Type 2
    • Nottingham, Notts, United Kingdom
      David Greenfield Human Physiology Unit, University of Nottingham
    Apr 5, 2022

    Cardiovascular Risk Factor Trial in Reading (Coconut oil, Butter, Vegetable oil)

    Completed
    • Cardiovascular Risk Factor
    • Coconut oil
    • +2 more
    • Reading, Berkshire, United Kingdom
      Department of Food and Nutritional Sciences, University of Readi
    Feb 21, 2022

    Obesity, Type 2 Diabetes, Metabolic Syndrome Trial in Boston (Dietary intervention)

    Enrolling by invitation
    • Obesity
    • +5 more
    • Dietary intervention
    • Boston, Massachusetts
      Massacusetts General Hospital
    May 25, 2022

    Healthy Trial in Singapore (Beverage powder with 12% oat bran processed with method A, Beverage powder with 12% oat bran

    Completed
    • Healthy
    • Beverage powder with 12% oat bran processed with method A
    • +4 more
    • Singapore, Singapore
      National University Hospital
    Sep 20, 2022

    Obesity, Weight Loss Trial in Beirut (Multidisciplinary weight loss program, Standard Care, Metformin Hcl 850Mg Tab)

    Recruiting
    • Obesity
    • Weight Loss
    • Multidisciplinary weight loss program
    • +2 more
    • Beirut, Riad El Solh, Lebanon
      American University of Beirut - Medical Center
    Aug 8, 2022

    Individuals at Risk of Developing Diabetes Trial in Adelaide (Intermittent Fasting (IF), Daily Restriction (DR), standard care

    Completed
    • Individuals at Risk of Developing Diabetes
    • Intermittent Fasting (IF)
    • +2 more
    • Adelaide, South Australia, Australia
      University of Adelaide
    Dec 20, 2021

    Amino Acid Trial in Bobigny (Whey Protein Isolate 894 Fonterra, Zein Sigma-Aldrich W555025, Protein-free test-meal)

    Completed
    • Amino Acid
    • Whey Protein Isolate 894 Fonterra
    • +2 more
    • Bobigny, France
      CRNH Ile de France
    May 31, 2022

    Type 2 Diabetes, Obesity Trial in Cambridge (0.9% Sodium-chloride, Exenatide (50ng/min for 30 minutes loading followed by

    Recruiting
    • Type 2 Diabetes
    • Obesity
    • 0.9% Sodium-chloride
    • +3 more
    • Cambridge, Cambridgeshire, United Kingdom
      Cambridge University Hospitals NHS Foundation Trust and The Univ
    Jan 18, 2022